390 related articles for article (PubMed ID: 15352223)
1. High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3.
Sitter B; Autti T; Tyynelä J; Sonnewald U; Bathen TF; Puranen J; Santavuori P; Haltia MJ; Paetau A; Polvikoski T; Gribbestad IS; Häkkinen AM
J Neurosci Res; 2004 Sep; 77(5):762-9. PubMed ID: 15352223
[TBL] [Abstract][Full Text] [Related]
2. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis.
Seitz D; Grodd W; Schwab A; Seeger U; Klose U; Nägele T
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1373-7. PubMed ID: 9726485
[TBL] [Abstract][Full Text] [Related]
3. High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease.
Pears MR; Cooper JD; Mitchison HM; Mortishire-Smith RJ; Pearce DA; Griffin JL
J Biol Chem; 2005 Dec; 280(52):42508-14. PubMed ID: 16239221
[TBL] [Abstract][Full Text] [Related]
4. Brain proton MR spectroscopy measurements in CLN3 disease.
Dang Do AN; Baker EH; Farmer CA; Soldatos AG; Thurm AE; Porter FD
Mol Genet Metab; 2023 May; 139(1):107584. PubMed ID: 37086568
[TBL] [Abstract][Full Text] [Related]
5. MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.
Righi V; Tugnoli V; Mucci A; Bacci A; Bonora S; Schenetti L
Oncol Rep; 2012 Oct; 28(4):1461-7. PubMed ID: 22824994
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of brain metabolites observed by HRMAS 1H NMR of intact tissue and solution 1H NMR of tissue extracts in SIV-infected macaques.
Ratai EM; Pilkenton S; Lentz MR; Greco JB; Fuller RA; Kim JP; He J; Cheng LL; González RG
NMR Biomed; 2005 Jun; 18(4):242-51. PubMed ID: 15759297
[TBL] [Abstract][Full Text] [Related]
7. Intralipid/Heparin Infusion Alters Brain Metabolites Assessed With 1H-MRS Spectroscopy in Young Healthy Men.
Karczewska-Kupczewska M; Nikolajuk A; Filarski R; Majewski R; Tarasów E
J Clin Endocrinol Metab; 2018 Jul; 103(7):2563-2570. PubMed ID: 29860500
[TBL] [Abstract][Full Text] [Related]
8. High-field localized 1H NMR spectroscopy in the anesthetized and in the awake monkey.
Pfeuffer J; Juchem C; Merkle H; Nauerth A; Logothetis NK
Magn Reson Imaging; 2004 Dec; 22(10):1361-72. PubMed ID: 15707786
[TBL] [Abstract][Full Text] [Related]
9. Localized proton magnetic resonance spectroscopy of cerebral metabolic disturbances in children with neuronal ceroid lipofuscinosis.
Brockmann K; Pouwels PJ; Christen HJ; Frahm J; Hanefeld F
Neuropediatrics; 1996 Oct; 27(5):242-8. PubMed ID: 8971744
[TBL] [Abstract][Full Text] [Related]
10. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3.
Chattopadhyay S; Pearce DA
Mol Genet Metab; 2000; 71(1-2):207-11. PubMed ID: 11001812
[TBL] [Abstract][Full Text] [Related]
11. Neuroradiological findings (MRS, MRI, SPECT) in infantile neuronal ceroid-lipofuscinosis (infantile CLN1) at different stages of the disease.
Vanhanen SL; Puranen J; Autti T; Raininko R; Liewendahl K; Nikkinen P; Santavuori P; Suominen P; Vuori K; Häkkinen AM
Neuropediatrics; 2004 Feb; 35(1):27-35. PubMed ID: 15002049
[TBL] [Abstract][Full Text] [Related]
12. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
Sanacora G; Gueorguieva R; Epperson CN; Wu YT; Appel M; Rothman DL; Krystal JH; Mason GF
Arch Gen Psychiatry; 2004 Jul; 61(7):705-13. PubMed ID: 15237082
[TBL] [Abstract][Full Text] [Related]
13. On the identification of cerebral metabolites in localized 1H NMR spectra of human brain in vivo.
Michaelis T; Merboldt KD; Hänicke W; Gyngell ML; Bruhn H; Frahm J
NMR Biomed; 1991 Apr; 4(2):90-8. PubMed ID: 1677588
[TBL] [Abstract][Full Text] [Related]
14. Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy.
Sinha S; Ekka M; Sharma U; P R; Pandey RM; Jagannathan NR
BMC Res Notes; 2014 Jan; 7():41. PubMed ID: 24433580
[TBL] [Abstract][Full Text] [Related]
15. [From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis].
Taschner PE; Losekoot M; Breuning MH; Hofman I; van Diggelen OP
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):300-3. PubMed ID: 15730038
[TBL] [Abstract][Full Text] [Related]
16. J-difference-edited MRS measures of γ-aminobutyric acid before and after acute caffeine administration.
Oeltzschner G; Zöllner HJ; Jonuscheit M; Lanzman RS; Schnitzler A; Wittsack HJ
Magn Reson Med; 2018 Dec; 80(6):2356-2365. PubMed ID: 29752742
[TBL] [Abstract][Full Text] [Related]
17. 1H-MR spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain.
Gussew A; Rzanny R; Güllmar D; Scholle HC; Reichenbach JR
Neuroimage; 2011 Jan; 54(2):1315-23. PubMed ID: 20869447
[TBL] [Abstract][Full Text] [Related]
18. Metabolic changes in the vicinity of brain contusions: a proton magnetic resonance spectroscopy and histology study.
Schuhmann MU; Stiller D; Skardelly M; Bernarding J; Klinge PM; Samii A; Samii M; Brinker T
J Neurotrauma; 2003 Aug; 20(8):725-43. PubMed ID: 12965052
[TBL] [Abstract][Full Text] [Related]
19. Human fetal brain chemistry as detected by proton magnetic resonance spectroscopy.
Brighina E; Bresolin N; Pardi G; Rango M
Pediatr Neurol; 2009 May; 40(5):327-42. PubMed ID: 19380068
[TBL] [Abstract][Full Text] [Related]
20. Measurement of brain glutamate using TE-averaged PRESS at 3T.
Hurd R; Sailasuta N; Srinivasan R; Vigneron DB; Pelletier D; Nelson SJ
Magn Reson Med; 2004 Mar; 51(3):435-40. PubMed ID: 15004781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
